Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: The end of an era?

Journal of Clinical Oncology

Volumn 25, Issue 35, 2007, Pages 5649-5654

  Mocellin, Simone ^a   Pilati, Pierluigi ^a   Lise, Mario ^a   Nitti, Donato ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE; FLUOROURACIL; FOLINIC ACID;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RISK; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; HAZARD RATIO; HEPATIC ARTERY; HUMAN; LIVER METASTASIS; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; HEPATIC ARTERY; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; PYRIMIDINES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 37649015497     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.12.1764     Document Type: Article

References (43)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin 56:106-130, 2006
2. Weitz J, Koch M, Debus J, et al: Colorectal cancer. Lancet 365:153-165, 2005
3. Lorenz M, Staib-Sebler E, Hochmuth K, et al: Surgical resection of liver metastases of colorectal carcinoma: Short and long-term results. Semin Oncol 27:112-119, 2000 (suppl 10)
4. Malafosse R, Penna C, Sa Cunha A, et al: Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol 12:887-894, 2001
5. Bentrem DJ, Dematteo RP, Blumgart LH: Surgical therapy for metastatic disease to the liver. Annu Rev Med 56:139-156, 2005
6. Holen KD, Saltz LB: New therapies, new directions: Advances in the systemic treatment of metastatic colorectal cancer. Lancet Oncol 2:290-297, 2001
7. Kelly H, Goldberg RM: Systemic therapy for metastatic colorectal cancer: Current options, current evidence. J Clin Oncol 23:4553-4560, 2005
8. Kemeny N, Fata F: Hepatic-arterial chemotherapy. Lancet Oncol 2:418-428, 2001
9. Allen PJ, Nissan A, Picon AI, et al: Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: An institutional experience of 544 consecutive cases. J Am Coll Surg 201:57-65, 2005
10. Skitzki JJ, Chang AE: Hepatic artery chemotherapy for colorectal liver metastases: Technical considerations and review of clinical trials. Surg Oncol 11:123-135, 2002
11. Cohen AD, Kemeny NE: An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist 8:553-566, 2003
12. Homsi J, Garrett CR: Hepatic arterial infusion of chemotherapy for hepatic metastases from colorectal cancer. Cancer Control 13:42-47, 2006
13. Chan R, Kerr D: Hepatic arterial chemotherapy for colorectal cancer liver metastases: A review of advances in 2003. Curr Opin Oncol 16:378-384, 2004
14. Bartlett DL, Berlin J, Lauwers GY, et al: Chemotherapy and regional therapy of hepatic colorectal metastases: Expert consensus statement. Ann Surg Oncol 13:1284-1292, 2006
15. Ong ES, Poirier M, Espat NJ: Hepatic intra-arterial chemotherapy. Ann Surg Oncol 13:142-149, 2006
16. Kelly RJ, Kemeny NE, Leonard GD: Current strategies using hepatic arterial infusion chemotherapy for the treatment of colorectal cancer. Clin Colorectal Cancer 5:166-174, 2005
17. Barber FD, Mavligit G, Kurzrock R: Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: A concise overview. Cancer Treat Rev 30:425-436, 2004
18. Chang AE, Schneider PD, Sugarbaker PH, et al: A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206:685-693, 1987
19. Kemeny N, Daly J, Reichman B, et al: Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma: A randomized trial. Ann Intern Med 107:459-465, 1987
20. Hohn DC, Stagg RJ, Friedman MA, et al: A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial. J Clin Oncol 7:1646-1654, 1989
21. Martin JK Jr, O'Connell MJ, Wieand HS, et al: Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer: A randomized trial. Arch Surg 125:1022-1027, 1990
22. Wagman LD, Kemeny MM, Leong L, et al: A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 8:1885-1893, 1990
23. Rougier P, Laplanche A, Huguier M, et al: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial. J Clin Oncol 10:1112-1118, 1992
24. Allen-Mersh TG, Earlam S, Fordy C, et al: Quality of life and survival with continuous hepaticartery floxuridine infusion for colorectal liver metastases. Lancet 344:1255-1260, 1994
25. Meta-Analysis Group in Cancer: Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88:252-258, 1996
26. Harmantas A, Rotstein LE, Langer B: Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver: Is there a survival difference? Meta-analysis of the published literature. Cancer 78:1639-1645, 1996
27. Lorenz M, Muller HH: Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 18:243-254, 2000
28. Kerr DJ, McArdle CS, Ledermann J, et al: Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: A multicentre randomised trial. Lancet 361:368-373, 2003
29. Kemeny NE, Niedzwiecki D, Hollis DR, et al: Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 24:1395-1403, 2006
30. Sutton AJ, Abrams KR, Jones DR, et al: Methods for Meta-Analysis in Medical Research. New York, NY, Wiley, 2000
31. Alderson P, Green S, Higgins JPT: Cochrane Reviewers' Handbook 4.2.2. New York, NY, Wiley, 2004
32. Parmar MK, Torri V, Stewart L: Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815-2834, 1998
33. Mocellin S, Hoon DS, Ambrosi A, et al: The prognostic value of circulating tumor cells in patients with melanoma: A systematic review and meta-analysis. Clin Cancer Res 12:4605-4613, 2006
34. Mocellin S, Hoon D, Pilati P, et al: The prognostic value of sentinel lymph node molecular ultrastaging in patients with melanoma: A systematic review and meta-analysis. J Clin Oncol 25:1588-1595, 2007
35. Dupont WD, Plummer WD Jr: Power and sample size calculations: A review and computer program. Control Clin Trials 11:116-128, 1990
36. Curran D, Sylvester RJ, Hoctin Boes G: Sample size estimation in phase III cancer clinical trials. Eur J Surg Oncol 25:244-250, 1999
37. Ducreux M, Ychou M, Laplanche A, et al: Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: A trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol 23:4881-4887, 2005
38. Murthy R, Xiong H, Nunez R, et al: Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: Preliminary results. J Vasc Interv Radiol 16:937-945, 2005
39. Pohlen U, Rieger H, Mansmann U, et al: Hepatic arterial infusion (HAI): Comparison of 5-fluorouracil, folinic acid, interferon alpha-2b and degradable starch microspheres versus 5-fluorouracil and folinic acid in patients with non-resectable colorectal liver metastases. Anticancer Res 26:3957-3964, 2006
40. Kemeny N, Eid A, Stockman J, et al: Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. J Surg Oncol 91:97-101, 2005
41. Kemeny N, Jarnagin W, Paty P, et al: Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 23:4888-4896, 2005
42. Fiorentini G, Cantore M, Rossi S, et al: Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: Results of a multi-centric randomized study. In Vivo 20:707-709, 2006
43. Mukai M, Oida Y, Tajima T, et al: Alternating hepatic arterial infusion and systemic chemotherapy for stage IV colorectal cancer with synchronous liver metastasis. Oncol Rep 16:865-870, 2006